Related Experiment Video
Updated: Nov 2, 2025

A Facile Protocol to Generate Site-Specifically Acetylated Proteins in Escherichia Coli
Published on: December 9, 2017
Molecular Characterization and Clinical Relevance of Lysine Acetylation Regulators in Urological Cancers
Jian Zhang1, Chunning Zhang2, Huali Jiang3
1Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, Guangzhou, China.
Background:
Lysine acetylation and deacetylation are posttranslational modifications that are able to link extracellular signals to intracellular responses. However, knowledge regarding the status of lysine regulators in urological cancers is still unknown.
Methods:
We first systematically analyzed the genetic and expression alterations of 31 lysine acetylation regulators in urological cancers. The correlation between lysine acetylation regulators and activation of cancer pathways was explored. The clinical relevance of lysine acetylation regulators was further analyzed.
Results:
We identified that there are widespread genetic alterations of lysine acetylation regulators, and that their expression levels are significantly associated with the activity of cancer hallmark-related pathways. Moreover, lysine acetylation regulators were found to be potentially useful for prognostic stratification. HDAC11 may act as a potential oncogene in cell cycle and oxidative phosphorylation of urological cancers.
Conclusion:
Lysine acetylation regulators are involved in tumorigenesis and progression. Our results provide a valuable resource that will guide both mechanistic and therapeutic analyses of the role of lysine acetylation regulators in urological cancers.
Insights
Lysine acetylation regulators are altered in urological cancers, impacting cancer pathways and prognosis. These findings offer insights into cancer development and potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Lysine acetylation and deacetylation are crucial posttranslational modifications linking cellular signals.
- The role of lysine acetylation regulators in urological cancers remains largely unexplored.
Purpose of the Study:
- To investigate genetic and expression alterations of lysine acetylation regulators in urological cancers.
- To explore the correlation between these regulators and cancer pathway activation.
- To analyze the clinical relevance of lysine acetylation regulators for patient stratification.
Main Methods:
- Systematic analysis of genetic and expression alterations in 31 lysine acetylation regulators.
- Exploration of correlations with cancer hallmark pathway activation.
- Clinical relevance assessment for prognostic stratification.
Main Results:
- Widespread genetic alterations and significant expression changes of lysine acetylation regulators identified.
- Expression levels correlate with the activity of cancer hallmark-related pathways.
- HDAC11 identified as a potential oncogene in cell cycle and oxidative phosphorylation in urological cancers.
Conclusions:
- Lysine acetylation regulators play a significant role in the tumorigenesis and progression of urological cancers.
- These regulators are potential biomarkers for prognostic stratification.
- The study provides a valuable resource for future mechanistic and therapeutic investigations.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Lysosomal Hydrolases
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation

